Clementia is a privately held clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for people living with rare diseases by exploiting the science of novel retinoic acid receptor gamma agonists to address bone diseases, including Fibrodysplasia Ossificans Progressiva (FOP).
View Top Employees from Clementia Pharmaceuticals Inc.| Website | https://www.clementiapharma.com |
| Ticker | CMTA |
| Revenue | $10 million |
| Employees | 19 (8 on RocketReach) |
| Founded | 2012 |
| Phone | (514) 940-3600 |
| Technologies |
JavaScript,
HTML,
PHP
+37 more
(view full list)
|
| Industry | Education, Organizations, Pharmaceuticals, Biopharma, Biotechnology, Health Care, Science and Engineering, Drug Manufacturing & Research, Medical, Healthcare |
| Web Rank | 13 Million |
| Keywords | Clementia Pharmaceuticals, Clarissa Desjardins, Palovarotene, Visiongate Files Bankruptcy, Clementia Investor Relations |
| Competitors | Aerpio Pharmaceuticals, Catabasis Pharmaceuticals, Inc., Patrys Limited, Precision Biologics, Soligenix, Inc. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies |
Looking for a particular Clementia Pharmaceuticals Inc. employee's phone or email?
Clementia Pharmaceuticals Inc. Questions
The Clementia Pharmaceuticals Inc. annual revenue was $10 million in 2023.
Madalon Meany is the Senior Medical Director PVRM of Clementia Pharmaceuticals Inc..
8 people are employed at Clementia Pharmaceuticals Inc..
The NAICS codes for Clementia Pharmaceuticals Inc. are [5417, 3254, 541, 32541, 32, 325, 54].
The SIC codes for Clementia Pharmaceuticals Inc. are [87, 873].
Top Clementia Pharmaceuticals Inc. Employees
-
34
-
34
-
1
-
-
Related Companies
